Skip to main content
Clinical Trials/NCT02360904
NCT02360904CompletedNot Applicable

A Yoga Program for Breast Cancer Patients Undergoing Chemotherapy: Effects on Quality of Life and Chemotherapy-associated Symptoms

Icahn School of Medicine at Mount Sinai1 site in 1 country50 target enrollmentStarted: April 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
change in quality of life

Study Overview

Brief Summary

The primary aim of this study is to assess and compare change in QOL during chemotherapy as measured by the Functional Assessment of Cancer Therapy-Breast (FACT-Breast) score between patients receiving yoga and those not receiving yoga. Secondary endpoints will include other measures of QOL such as sleep quality measured with the Pittsburg Sleep Quality Inventory (PSQI), anxiety and depression using Hospital Anxiety and Depression Scale (HADS), and adherence to yoga and to chemotherapy treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age>18 years
  • •History of stage I-III breast cancer
  • •Patient scheduled to receive or within 2 weeks of receiving intravenous chemotherapy for their breast cancers
  • •Eastern Cooperative Oncology Group Performance status of <3
  • •Ability to understand English

Exclusion Criteria

  • •Planning to start yoga on their own within the next 12 weeks
  • •Maintained a regular personal practice or yoga within the 3 months before enrolling onto the study
  • •Severe chronic obstructive pulmonary disease
  • •Class III or IV heart failure
  • •Child C cirrhosis
  • •End-Stage renal disease
  • •Exclusion Criteria:
  • •Planning to start yoga on their own within the next 12 weeks
  • •Maintained a regular personal practice or yoga within the 3 months before enrolling onto the study
  • •Severe chronic obstructive pulmonary disease
  • •Class III or IV heart failure
  • •Child C cirrhosis
  • •End-Stage renal disease

Arms & Interventions

start yoga classes immediately

Experimental

12 weekly 60-minute yoga classes taught by a certified yoga instructor with cancer-specific yoga training that will commence concurrently with the start of chemotherapy.

Intervention: Yoga (Other)

Start yoga classes after 3 months

Active Comparator

12 weekly 60-minute yoga classes taught by a certified yoga instructor with cancer-specific yoga training that will commence 3 months after start of chemotherapy

Intervention: Yoga (Other)

Outcomes

Primary Outcomes

change in quality of life

Time Frame: 12 weeks

to assess and compare change in QOL during chemotherapy as measured by the Functional Assessment of Cancer Therapy-Breast (FACT-Breast) score between patients receiving yoga immediately and those start yoga 3 months later.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Theresa Shao

Assistant Professor

Icahn School of Medicine at Mount Sinai

Study Sites (1)

Loading locations...

Similar Trials